BrandonMatthewHayes-LattinMD

Hematology • Portland, OR

Hematologic Oncology

Professor of Medicine, Medical Director of Hematology and Medical Oncology

Join to view full profile

Dr. Hayes-Lattin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Hayes-Lattin's full profile

Already have an account?

Office
3181 SW Sam Jackson Park Rd
# L586
Portland, OR 97239
Phone+1 503-494-8534

Fax+1 503-494-3257

Education & Training

Oregon Health & Science University (OHSU Health)Fellowship, Hematology and Medical Oncology, 2001 - 2004
Oregon Health & Science University (OHSU Health)Residency, Internal Medicine, 1997 - 2000
University of Washington School of MedicineClass of 1997, MD
StanfordBS, 1988 - 1992

Certifications & Licensure

WA State Medical License 2005 - 2026
OR State Medical License 1998 - 2025
American Board of Internal Medicine Hematology

Clinical Trials

Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
Unknown status
Phase 2
Flu/TBI in Treating Patients Not Responding to Previous Hormone Therapy Start of enrollment: 2005 Jan 01
Withdrawn
Phase 2
Fludarabine and Total-Body Irradiation in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Metastatic Kidney Cancer That Cannot Be Removed By Surgery Start of enrollment: 2005 Jun 01
Terminated
Phase 2
Effectiveness of Etanercept for Idiopathic Pneumonia Syndrome Following Stem Cell Transplantation (BMT CTN 0403) Start of enrollment: 2007 Aug 01
Completed
Phase 3
Pegaspargase and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia Start of enrollment: 2009 Jun 01
Terminated
Phase 2
Join now to see all

Publications & Presentations

PubMed

Multisystem ALK-Positive Histiocytosis With DCTN1::ALK Fusion in an Adult, Responsive to Alectinib: Case Report and Literature Review.
Gregory S Phillips, Maxwell Knapp, Keith C Olsen, William Martin, Brandon Hayes-Lattin
Journal of Cutaneous Pathology. 2024-10-15
Sociodemographic Factors Influencing Access to Chimeric Antigen T-Cell Receptor Therapy for Patients With Non-Hodgkin Lymphoma.
Somya Khare, Staci Williamson, Brittany O'Barr, Levanto Schachter, Andy Chen
Clinical Lymphoma, Myeloma & Leukemia. 2024-09-27
Thromboprophylaxis with intermediate dose enoxaparin during asparaginase containing induction for young adults with acute lymphoblastic leukemia.
Hong De Sa, Thomas Deloughery, Andy Kaempf, Curtis Lachowiez, Jessica Leonard
Leukemia & Lymphoma. 2024-09-18

Press Mentions

Raising Awareness of the Financial Impact of Cancer on Young Adult SurvivorsJuly 10th, 2018
How to Help Young Patients Preserve Their FertilityAugust 10th, 2017

Professional Memberships

American College of Physicians - ACP
Member
American Society of Clinical Oncology - ASCO
Member